Market Leadership Acentus stands out as a leading provider of continuous glucose monitors (CGMs) delivered directly to homes, emphasizing its strong position in the healthcare supply chain for diabetic care.

Strategic Acquisition The recent sale of assets to Henry Schein, Inc. suggests opportunities for synergy with a major healthcare solutions provider, opening pathways for expanded distribution and cross-selling medication and medical supplies.

Healthcare Focus With a family-owned ethos prioritizing patient satisfaction over profits, Acentus demonstrates a commitment to quality healthcare services, appealing to clinicians and patients seeking reliable diabetes management solutions.

Technological Edge Acentus’s proprietary referral platform and real-time insights for clinicians highlight its advanced tech capabilities, offering opportunities to integrate or enhance digital solutions in healthcare workflows.

Financial Strength Generating between $50 million and $100 million in revenue with a relatively lean team, Acentus has significant market traction, indicating potential for scalable growth and increased sales engagement.